Sanofi India Limited (SANOFI) — Announcement

· NSE Neutral

Sanofi India disclosed a GST refund rejection for the 2014-15 to 2017-18 period amounting to INR 11.63 crores, where the State GST authority rejected the refund claim because the mandatory pre-deposit was treated as central excise liability rather than tax under CGST Act, rendering the State GST refund application invalid.

📄 View Original Announcement (PDF)

About Sanofi India Limited (SANOFI)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹7,411.02 Cr P/E: 17.9

View full SANOFI stock details →

📡 Get AI alerts when SANOFI files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SANOFI — Free

📊 More SANOFI filings

See all SANOFI filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when SANOFI files new disclosures

Track SANOFI filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SANOFI — Free

Free account · 2 AI queries/day